ALC:NYSE
Alcon AG
70,17 US$
arrow_downward
-0,69%(-0,49) 1D
70,17 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 23 ოქტ, 16:00:05 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
70,16 US$
High
70,46 US$
Low
69,54 US$
Mkt. cap
28,81 მლრდ.
Avg. vol.
1,77 მლნ.
Volume
2,59 მლნ.
52-wk high
87,64 US$
52-wk low
61,84 US$
Beta
0,88
Shares outstanding
483,40 მლნ.
No. of employees
25 ათ.
Open
70,16 US$
High
70,46 US$
Low
69,54 US$
Mkt. cap
28,81 მლრდ.
Avg. vol.
1,77 მლნ.
Volume
2,59 მლნ.
52-wk high
87,64 US$
52-wk low
61,84 US$
Beta
0,88
Shares outstanding
483,40 მლნ.
No. of employees
25 ათ.
News stories
From web sources and news partners
GuruFocus
·
21 საათის წინ
Alcon Inc (ALC) Shares Surge 4.8% -- What GF Score of 74 Tells I
Fierce Pharma
·
2 დღის წინ
Alcon ponies up $550M for Neurotech, bagging approved cell therapy implant Encelto
Yahoo Finance
·
3 დღის წინ
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEOდავიდ ჯეი ენდიკოტ
Employees25 ათ.
Founded1945
Headquartersჟენევა, ჟენევის კანტონი, შვეიცარია
SectorMedical device
Websitealcon.com